Vlad Vitoc
Amministratore Delegato presso MAIA BIOTECHNOLOGY, INC.
Patrimonio netto: 3 M $ in data 30/06/2024
Profilo
Dr. Vlad Vitoc is a Chairman, President & Chief Executive Officer at MAIA Biotechnology, Inc. and a Chief Executive Officer & Director at DGD Pharmaceuticals Corp.
He is on the Board of Directors at DGD Pharmaceuticals Corp.
He received his MBA from the University of South Carolina and a doctorate degree from Iuliu Hatieganu University of Medicine & Pharmacy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC.
4.67% | 26/04/2024 | 1 019 121 ( 4.67% ) | 3 M $ | 30/06/2024 |
Posizioni attive di Vlad Vitoc
| Società | Posizione | Inizio |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Amministratore Delegato | 03/08/2018 |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Amministratore Delegato | - |
Formazione di Vlad Vitoc
| Iuliu Hatieganu University of Medicine & Pharmacy | Doctorate Degree |
| University of South Carolina | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MAIA BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
DGD Pharmaceuticals Corp.
DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Vlad Vitoc
